𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

✍ Scribed by Pallanti, Stefano; Bernardi, Silvia; Antonini, Sarah; Singh, Nikhilesh; Hollander, Eric

Book ID
120634698
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2009
Tongue
English
Weight
150 KB
Volume
23
Category
Article
ISSN
1172-7047

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Amisulpiride augmentation in treatment r
Amisulpiride augmentation in treatment resistant obsessive–compulsive disorder: an open trial
✍ Γ–zmen Metin; Kemal Yazici; Senel Tot; Aylin Ertekin Yazici πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 60 KB πŸ‘ 1 views

## Abstract Despite the effectiveness of clomipramine and selective serotonin reuptake inhibitors (SSRIs) in the treatment of obsessive–compulsive disorder (OCD), 40% to 60% of patients who receive an adequate treatment with these agents have significant persisting symptoms. Newer atypical antipsyc